You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Medical Care

Global Checkpoint Inhibitors for Treating Cancer Market Analysis 2016-2020 and Forecast 2021-2026

Snapshot

Checkpoint inhibitors for treating cancer is a type of drug that blocks certain proteins made by some types of immune system cells, such as T cells, and some cancer cells. These proteins help keep immune responses in check and can keep T cells from killing cancer cells. When these proteins are blocked, the “brakes” on the immune system are released and T cells are able to kill cancer cells better. Examples of checkpoint proteins found on T cells or cancer cells include PD-1/PD-L1 and CTLA-4/B7-1/B7-2.
The global Checkpoint Inhibitors for Treating Cancer market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Checkpoint Inhibitors for Treating Cancer by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
PD-1 inhibitors
PD-L1 inhibitors
CTLA-4 inhibitors

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Bristol-Myers Squibb(BMS)
Merck
Roche

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Melanoma treatment
Bladder cancer treatment
Others

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Table of Contents
1 Industry Overview
1.1 Checkpoint Inhibitors for Treating Cancer Industry
Figure Checkpoint Inhibitors for Treating Cancer Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Checkpoint Inhibitors for Treating Cancer
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Checkpoint Inhibitors for Treating Cancer
1.2.2 Downstream
Table Application Segment of Checkpoint Inhibitors for Treating Cancer
Table Global Checkpoint Inhibitors for Treating Cancer Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Checkpoint Inhibitors for Treating Cancer Market by Type
3.1 By Type
3.1.1 PD-1 inhibitors
Table Major Company List of PD-1 inhibitors
3.1.2 PD-L1 inhibitors
Table Major Company List of PD-L1 inhibitors
3.1.3 CTLA-4 inhibitors
Table Major Company List of CTLA-4 inhibitors
3.2 Market Size
Table Global Checkpoint Inhibitors for Treating Cancer Market 2016-2020, by Type, in USD Million
Figure Global Checkpoint Inhibitors for Treating Cancer Market Growth 2016-2020, by Type, in USD Million
Table Global Checkpoint Inhibitors for Treating Cancer Market 2016-2020, by Type, in Volume
Figure Global Checkpoint Inhibitors for Treating Cancer Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Checkpoint Inhibitors for Treating Cancer Market Forecast 2021-2026, by Type, in USD Million
Table Global Checkpoint Inhibitors for Treating Cancer Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 Bristol-Myers Squibb(BMS) (Company Profile, Sales Data etc.)
4.1.1 Bristol-Myers Squibb(BMS) Profile
Table Bristol-Myers Squibb(BMS) Overview List
4.1.2 Bristol-Myers Squibb(BMS) Products & Services
4.1.3 Bristol-Myers Squibb(BMS) Business Operation Conditions
Table Business Operation of Bristol-Myers Squibb(BMS) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Merck (Company Profile, Sales Data etc.)
4.2.1 Merck Profile
Table Merck Overview List
4.2.2 Merck Products & Services
4.2.3 Merck Business Operation Conditions
Table Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Roche (Company Profile, Sales Data etc.)
4.3.1 Roche Profile
Table Roche Overview List
4.3.2 Roche Products & Services
4.3.3 Roche Business Operation Conditions
Table Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Checkpoint Inhibitors for Treating Cancer Sales Revenue 2016-2020, by Company, in USD Million
Table Global Checkpoint Inhibitors for Treating Cancer Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Checkpoint Inhibitors for Treating Cancer Sales Revenue Share in 2020, by Company, in USD Million
Table Global Checkpoint Inhibitors for Treating Cancer Sales Volume 2016-2020, by Company, in Volume
Table Global Checkpoint Inhibitors for Treating Cancer Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Checkpoint Inhibitors for Treating Cancer Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Checkpoint Inhibitors for Treating Cancer Market Concentration, in 2020
Figure Europe Checkpoint Inhibitors for Treating Cancer Market Market Concentration, in 2020
Figure Asia-Pacific Checkpoint Inhibitors for Treating Cancer MMarket Concentration, in 2020
Figure South America Checkpoint Inhibitors for Treating Cancer Market Concentration, in 2020
Figure Middle East & Africa Checkpoint Inhibitors for Treating Cancer Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Melanoma treatment
Figure Checkpoint Inhibitors for Treating Cancer Demand in Melanoma treatment, 2016-2020, in USD Million
Figure Checkpoint Inhibitors for Treating Cancer Demand in Melanoma treatment, 2016-2020, in Volume
6.1.2 Demand in Bladder cancer treatment
Figure Checkpoint Inhibitors for Treating Cancer Demand in Bladder cancer treatment, 2016-2020, in USD Million
Figure Checkpoint Inhibitors for Treating Cancer Demand in Bladder cancer treatment, 2016-2020, in Volume
6.1.3 Demand in Others
Figure Checkpoint Inhibitors for Treating Cancer Demand in Others, 2016-2020, in USD Million
Figure Checkpoint Inhibitors for Treating Cancer Demand in Others, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Checkpoint Inhibitors for Treating Cancer Demand Forecast 2021-2026, by Application, in USD Million
Figure Checkpoint Inhibitors for Treating Cancer Market Growth 2021-2026, by Application, in USD Million
Figure Checkpoint Inhibitors for Treating Cancer Market Share in 2026, by Application, in USD Million
Table Checkpoint Inhibitors for Treating Cancer Demand Forecast 2021-2026, by Application, in Volume
Table Checkpoint Inhibitors for Treating Cancer Market Growth 2021-2026, by Application, in Volume
Table Checkpoint Inhibitors for Treating Cancer Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Checkpoint Inhibitors for Treating Cancer Production 2016-2020, by Region, in USD Million
Table Checkpoint Inhibitors for Treating Cancer Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Checkpoint Inhibitors for Treating Cancer Market 2016-2020, by Region, in USD Million
Table Global Checkpoint Inhibitors for Treating Cancer Market Share 2016-2020, by Region, in USD Million
Table Global Checkpoint Inhibitors for Treating Cancer Market 2016-2020, by Region, in Volume
Table Global Checkpoint Inhibitors for Treating Cancer Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2016-2020, in USD Million
Figure North America Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Checkpoint Inhibitors for Treating Cancer Market Size 2016-2020, by Country, in USD Million
Table North America Checkpoint Inhibitors for Treating Cancer Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2016-2020, in USD Million
Figure Europe Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Checkpoint Inhibitors for Treating Cancer Market Size 2016-2020, by Country, in USD Million
Table Europe Checkpoint Inhibitors for Treating Cancer Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Checkpoint Inhibitors for Treating Cancer Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Checkpoint Inhibitors for Treating Cancer Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2016-2020, in USD Million
Figure South America Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Checkpoint Inhibitors for Treating Cancer Market Size 2016-2020, by Country, in USD Million
Table South America Checkpoint Inhibitors for Treating Cancer Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Checkpoint Inhibitors for Treating Cancer Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Checkpoint Inhibitors for Treating Cancer Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Checkpoint Inhibitors for Treating Cancer Market Forecast 2021-2026, by Region, in USD Million
Table Checkpoint Inhibitors for Treating Cancer Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
  • FORMAT: PDF
  • PUBLISHED DATE: Feb, 2021
  • NO OF PAGES: 44235